PLoS ONE · 2013 · 49 citations · 44 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationMolecular VirologyVaccinologySubunit VaccinesVaccinationVaccine PlatformsVector-based VaccinesViral VaccinesViral Vector VaccinesAdenoviral Vaccine VectorsAdenovirus VaccinesAdenovirus VectorsIntranasal AdministrationPre-existing ImmunityTransgene ImmunogenicityUniversal Influenza VaccinesUniversal Vaccines
Among approximately 1000 adenoviruses from chimpanzees and bonobos studied recently, the Pan Adenovirus type 3 (PanAd3, isolated from a bonobo, Pan paniscus) has one of the best profiles for a vaccine vector, combining potent transgene immunogenicity with minimal pre-existing immunity in the human population. In this study, we inserted into a replication defective PanAd3 a transgene expressing a fusion protein of conserved influenza antigens nucleoprotein (NP) and matrix 1 (M1). We then studied antibody and T cell responses as well as protection from challenge infection in a mouse model. A single intranasal administration of PanAd3-NPM1 vaccine induced strong antibody and T cell responses, and protected against high dose lethal influenza virus challenge. Thus PanAd3 is a promising candidate vector for vaccines, including universal influenza vaccines.
44
The annual production cycle for influenza vaccine
C. Gerdil · Vaccine · 2003 · 533 citations
Veterinary Medicine, Infectious Diseases, Preventive Medicine +14
J W Yewdell, Jack R. Bennink, Geoffrey L. Smith et al. · Proceedings of the National Academy of Sciences · 1985 · 524 citations · Full text